HOME >> MEDICINE >> NEWS
Angina sufferers find significant relief with noninvasive technique

Angina patients whose intense, often suffocating chest pains can not be reliably relieved by medication or invasive treatments can gain significant pain reduction from a little-used medical procedure that appears to increase heart blood supply, a new study has found.

In the first controlled trial of the painless, non-invasive treatment known as enhanced external counterpulsation (EECP), patients experienced less frequent angina pain and had less need for nitroglycerin to control pain than did a control group of angina patients.

The results are published in the June issue of the Journal of the American College of Cardiology.

Nationally, about 15 million people suffer from angina, more than two million chronically. The number is expected to increase as the population ages. And for almost all of these people, neither drugs nor vascular surgery provide complete relief.

"To find something that is very safe and effective in this group of patients is very gratifying," said Tony Chou, MD, assistant professor of medicine at UC San Francisco, a clinical cardiologist at UCSF Stanford Health Care and co-author of the report in the cardiology journal.

Patients undergoing the EECP treatment lie on a table and wear a series of cuffs on their legs. At the precise moment of every heartbeat when the heart relaxes, the cuffs briefly inflate. This is thought to reduce the heart's workload, increase its pumping efficiency and improve cardiac bloodflow. The treatment usually involves 35 one-hour sessions.

"The angina patients we treated with EECP have not found relief from any other treatment -- from medications, angioplasty or surgery. They are a very frustrated group of patients for whom we don't have anything to offer. This treatment functions almost like a very good medication," Chou said.

The technique, largely developed in China, has been tested clinically in various forms over the past 30 years, with many reports of major success. But until now, no
'"/>

Contact: Wallace Raaven
wraaven@pubaff.ucsf.edu
415-476-2557
University of California - San Francisco
1-Jun-1999


Page: 1 2 3

Related medicine news :

1. American Heart Association Comment: Abciximab In Patients With Refractory Unstable Angina In Relation To Serum Troponin T Levels
2. Mayo Clinic Cardiologist Available To Discuss New Guidelines On Treatment Of Stable Angina
3. Drug Reduces Heart Attack, Death Rates In Patients With Unstable Angina
4. Study Leads To New Standard Of Care For Treating Unstable Angina: Heart-Attack Risk Reduced By 47% With Use Of Tirofiban
5. Why asthma sufferers struggle with the common cold
6. Drugs used to treat Alzheimers in nursing homes are worsening sufferers illness
7. An implanted nerve stimulator helps drop foot sufferers walk faster and better
8. Risk of stroke doubles for migraine sufferers
9. Chronic sinusitis sufferers have enhanced immune responses to fungi
10. Study finds fibromyalgia prohibits sufferers from breast-feeding
11. New hope for HIV sufferers

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian ... On The Brink” is the creation of published author, William Nowers. Captain Nowers ... a WWII veteran, he spent thirty years in the Navy. Following his career ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... are now treating sleep apnea using cutting-edge Oventus O2Vent technology. As ... serious sleep disorder characterized by frequent cessation in breathing. Oral appliances can offer ...
(Date:10/12/2017)... ... 2017 , ... The company has developed a suite of ... authorities worldwide. From Children’s to Adults 50+, every formula has been developed by ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, Preservative ...
(Date:10/12/2017)... ... ... The American College of Medical Informatics (ACMI) will present the 2017 Morris F. ... AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium is taking place ... the field of medical informatics, this prestigious award is presented to an individual whose ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: ... develop to enable prevention of a major side effect of chemotherapy in children. ... pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a dose ...
Breaking Medicine News(10 mins):
(Date:10/10/2017)... , Oct. 10, 2017   West Pharmaceutical ... innovative solutions for injectable drug administration, today shared the ... ID Adapter for improving the intradermal administration of polio ... Skin Vaccination Summit in May 2017 by Dr. ... Polio Department, World Health Organization (WHO), and recently published ...
(Date:10/4/2017)... Centers for Disease Control and Prevention (CDC), influenza vaccination should take ... communities across Massachusetts , Connecticut , ... through the end of the month. *Some exclusions apply ... ... by the end of October, according to the Centers for Disease Control ...
(Date:10/2/2017)... , Oct. 2, 2017  AllianceRx Walgreens Prime, ... formed by Walgreens and pharmacy benefit manager Prime Therapeutics ... new brand, which included the unveiling of new signage ... , as well as at a few other company-owned ... new brand to patients, some of whom will begin ...
Breaking Medicine Technology:
Cached News: